Leveraging High Content Phenotypic Screening to Study More Complex and Predictive Disease Models for Drug Discovery

Dr. Eberhard Krausz, from VIB, has the responsibility of translating research findings into drug discovery programs. Advocating the use of cell based screening and assay approaches to drug discovery, Dr. Eberhard discusses in this video how he first began using PerkinElmer’s instruments over ten years ago. Dr. Eberhard recommends PerkinElmer’s latest Opera Phenix High Content Screening System, suggesting it will continue to aid in future studies of complex, predictive disease models to identify new chemicals for drug discovery and development.